NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
3.060
-0.430 (-12.32%)
At close: Oct 14, 2026, 4:00 PM EDT
3.200
+0.140 (4.58%)
After-hours: Oct 14, 2026, 6:15 PM EDT
NeuroSense Therapeutics Employees
NeuroSense Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes NeuroSense Therapeutics the 38,791st largest employer in the world and 5,647th in the United States.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$654,412
Market Cap
5.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -1 | -5.56% |
| Dec 31, 2023 | 18 | 4 | 28.57% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Imunon | 20 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| Traws Pharma | 7 |
| Lexaria Bioscience | 7 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
NRSN News
- 1 day ago - NeuroSense secures Nasdaq hearing date as PrimeC approaches milestones - TheFly
- 1 day ago - NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones - PRNewsWire
- 2 days ago - NeuroSense downgraded to Neutral from Buy at Roth Capital - TheFly
- 12 days ago - NeuroSense Provides Update on Nasdaq Listing Compliance - PRNewsWire
- 16 days ago - NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - PRNewsWire
- 16 days ago - NeuroSense target adjusted to $52 from $8 at H.C. Wainwright - TheFly
- 19 days ago - NeuroSense Provides Business Update and Progress for the First Half of 2026 - PRNewsWire
- 4 weeks ago - Neurosense Therapeutics Ltd trading halted, news pending - TheFly